Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jose A. Cancelas
Observed names:
Jose A Cancelas,
José A. Cancelas
Institutions:
Cincinnati Children's Hospital Medical Center,
Harvard University,
Dana-Farber Cancer Institute,
Dana-Farber/Harvard Cancer Center,
University of Cincinnati,
University of Cincinnati Medical Center
show all 6
Observed institutions:
Cincinnati Children's Hospital Medical Center,
Harvard University,
Dana-Farber Cancer Institute,
Dana-Farber/Harvard Cancer Center,
University of Cincinnati,
University of Cincinnati Medical Center
show all 6
ORCID:
0000-0002-1291-7233
Observed ORCID:
0000-0002-1291-7233
OpenAlex ID:
A5135563453
A CAR-T tonic signaling code predicts anti-tumor efficacy in diffuse midline glioma
2026
·
Bing Deng
, Xiaowen Zhong
, et al.
·
Neuro-Oncology
·
1
Dynamic myeloid suppressor states in cancer and inflammation and their therapeutic potential
2026
·
Alexandra Pommier
, Jose A. Cancelas
·
Current Opinion in Hematology
·
1
Novel In-line Filter Reduces ABO Circulating Antibodies in Whole Blood
2026
·
Gregory C Wetmore
, Ryan C Chae
, et al.
·
Military Medicine
·
1
Quantification of Human Platelet Clearance In Vitro and in Xenotransfused Animals
2026
·
Shailaja Hegde
, Yi Zheng
, et al.
·
Methods in molecular biology
The need for dried plasma—Still a national issue: Where are we and recommendations
2026
·
Anthony E. Pusateri
, Shibani Pati
, et al.
·
Transfusion
CD137 in cancer therapy – bench to bedside
2026
·
Kathrine S. Rallis
, Jessica J. Liegel
, et al.
·
Immunotherapy
Next generation spray‐dried on‐demand plasma: A multicenter, randomized, dose‐escalation, first‐in‐human safety study
2026
·
Jose A. Cancelas
, Lisa Buckley
, et al.
·
Transfusion
Bone marrow stem cell connexins: misconceptions and new insights
2026
·
Abhishek K. Singh
, Kathrine S. Rallis
, et al.
·
Blood
Show more works
View as search
Works count:
8
Citation count:
3
H-index:
1
I10-index:
Year
Topic
Type